Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Arena Pharma Skyrockets on Heart Disease Data, Stock Could Still Double -Firm Says
Arena Pharma Skyrockets on Heart Disease Data, Stock Could Still Double -Firm Says
Arena Pharma Skyrockets on Heart Disease Data, Stock Could Still Double -Firm Says
Submitted by
admin
on July 17, 2017 - 7:05pm
Source:
TheStreet.com
News Tags:
Arena Pharmaceuticals
ralinepag
PAH
pulmonary arterial hypertension
Headline:
Arena Pharma Skyrockets on Heart Disease Data, Stock Could Still Double -Firm Says
Do Not Allow Advertisers to Use My Personal information